Zimmer Biomet Holdings (ZBH) Income from Continuing Operations (2009 - 2026)
Zimmer Biomet Holdings (ZBH) recorded quarterly Income from Continuing Operations of 238300000.0 in Q1 2026, down 10.21% quarter-over-quarter from 265400000.0 in Q4 2025, and up 30.58% on a YoY basis from 182500000.0 in Q1 2025.
Zimmer Biomet Holdings (ZBH) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 238300000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 30.58% year-over-year to 238300000.0; the TTM figure through Mar 2026 stood at 888300000.0 (up 33.96% YoY), while the FY2025 annual figure was 832600000.0, up 27.43% from the prior year.
- Income from Continuing Operations was 238300000.0 for Q1 2026 at Zimmer Biomet Holdings, down from 265400000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 419700000.0 in Q4 2023 to a low of 11700000.0 in Q4 2024.
- Historically, Income from Continuing Operations has averaged 193111764.71 across 5 years, with a median of 194200000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations sank 102.79% in 2024, then surged 2368.38% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 112200000.0 in 2022, then soared by 274.06% to 419700000.0 in 2023, then tumbled by 102.79% to 11700000.0 in 2024, then soared by 2368.38% to 265400000.0 in 2025, then decreased by 10.21% to 238300000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 238300000.0 (Q1 2026), 265400000.0 (Q4 2025), and 231200000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 238.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 238.30 Mn |
| Dec 31, 2025 | 265.40 Mn |
| Sep 30, 2025 | 231.20 Mn |
| Jun 30, 2025 | 153.40 Mn |
| Mar 31, 2025 | 182.50 Mn |
| Dec 31, 2024 | -11.70 Mn |
| Sep 30, 2024 | 249.20 Mn |
| Jun 30, 2024 | 243.10 Mn |
| Mar 31, 2024 | 172.80 Mn |
| Dec 31, 2023 | 419.70 Mn |
| Sep 30, 2023 | 162.80 Mn |
| Jun 30, 2023 | 209.90 Mn |
| Mar 31, 2023 | 232.70 Mn |
| Dec 31, 2022 | 112.20 Mn |
| Sep 30, 2022 | 194.20 Mn |
| Jun 30, 2022 | 154.00 Mn |
| Mar 31, 2022 | 73.20 Mn |
| Dec 31, 2021 | 64.10 Mn |
| Sep 30, 2021 | 162.40 Mn |
| Jun 30, 2021 | 144.80 Mn |